URGN / UroGen Pharma Ltd. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

UroGen Pharma Ltd.
US ˙ NasdaqGM ˙ IL0011407140

Utestående aktier 48,721,701 shares
Insideraktier3 830 492 shares
Insynsägande7,86 %
Totalt antal insynspersoner23
Insider Sentiment Score

Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.

Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.

Uppdateringsfrekvens: Dagligen

Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.

Office Sentiment Score

Officersentiment Score hittar företag som köps av Corporate Officers.

Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.

Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.

Uppdateringsfrekvens: Dagligen

Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.

Viktiga insidernyckeltal

Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.

Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).

Nettoantalet insiders som köper (rankning)

-1 ( )
9475 out of 10948

Nettoantalet insiders som köper är den totala mängden insiders som säljer minus det totala antalet insiders som säljer under de senaste 90 dagarna. Percentilrankningen visas här (intervall från 0 till 100%).

Procent av flytande köpta av insiders (ranking)

-0.023% ( )
9649 out of 10786

Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.

Insiderhandelsdiagram

UroGen Pharma Ltd. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.

Insiderlista och lönsamhetsstatistik

Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.

See our leaderboard of most profitable insider traders.

Insider Genomsnitt vinst (%) Aktier
Ägda
Delad
Justerad
Ron Bentsur Chief Executive Officer, Director - [D] [O] 76 226 76 226
Cynthia M Butitta Director - [D] 2 000 2 000
Barrett Elizabeth A. Chief Executive Officer - [O] 326 691 326 691
Arie Belldegrun Director - [D] 408 693 408 693
Fred E Cohen Director - [D] 69 339 69 339
Chris Degnan Chief Financial Officer - [O] 2 280 2 280
Kathryn E Falberg 10 000
Insider Genomsnitt vinst (%) Aktier
Ägda
Delad
Justerad
Molly Henderson Chief Financial Officer - [O] 5 248 5 248
Stuart Holden Director - [D] 2 000 2 000
Dong Kim Chief Financial Officer - [O] 37 753 37 753
Jay Moorin 10% Owner - [10%] 1 242 031 1 242 031
Stephen Mullennix Chief Operating Officer - [O] 10 084 10 084
Ran Nussbaum Director - [D] 1 437 169 1 437 169
Pfreundschuh Peter P. Chief Financial Officer - [O] 10 405 10 405
ProQuest Associates IV LLC 10% Owner - [10%] 1 242 031 1 242 031
Insider Genomsnitt vinst (%) Aktier
Ägda
Delad
Justerad
ProQuest Investments IV, L.P. 10% Owner - [10%] 1 242 031 1 242 031
Robinson James A. Jr. Director - [D] 6 000 6 000
Alain Schreiber 10% Owner - [10%] 1 242 031 1 242 031
Mark Schoenberg Chief Medical Officer - [O] 134 985 134 985
Jason Drew Smith General Counsel - [O] 55 588 55 588
Shawn Tomasello 10 000
Leana Wen Director - [D] 2 000 2 000
Daniel George Wildman Director - [D] 2 000 2 000

Report errors via our new Insider Auditing Tool

Track Records av insiderköp - Kortsiktig vinstanalys

I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i URGN / UroGen Pharma Ltd.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.

Handelsdatum Insider Rapporterade
aktier
Rapporterat
pris
Justerade
aktier
Justerat
pris
Kostnadsbasis Dagar til
Max
Pris vid
Max
Maximal
vinst ($)
Maximal avkastning (%)
2021-11-18 Schoenberg Mark 160 13,1000 160 13,1000 2 096 6 12.76 −54 −2,60
2021-05-17 Henderson Molly 2 500 15,8500 2 500 15,8500 39 625
2021-05-17 Smith Jason Drew 2 500 15,7100 2 500 15,7100 39 275
2020-12-14 Barrett Elizabeth A. 10 000 18,5000 10 000 18,5000 185 000
2019-11-21 Barrett Elizabeth A. 7 530 28,0000 7 530 28,0000 210 840
2019-11-20 Barrett Elizabeth A. 7 470 28,0000 7 470 28,0000 209 160
2019-11-19 Schoenberg Mark 1 960 28,1700 1 960 28,1700 55 213
2019-11-15 Barrett Elizabeth A. 1 548 26,0000 1 548 26,0000 40 248
2019-03-21 Schoenberg Mark 272 37,0090 272 37,0090 10 066

Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.

URGN / UroGen Pharma Ltd. Insider Trades
Track Records av insiderförsäljning - Kortsiktig förlustanalys

I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i URGN / UroGen Pharma Ltd.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .

Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.

Handelsdatum Insider Rapporterade
aktier
Rapporterat
pris
Justerade
aktier
Justerat
pris
Kostnadsbasis Dagar til
Min
Pris vid
Min
Maximal förlust
undvikits ($)
Maximal förlust
undvikits ($)
2026-02-03 Smith Jason Drew 2 654 19,6900 2 654 19,6900 52 257 55 17.0000 −7 139 −13,66
2026-02-03 Smith Jason Drew 1 608 19,6900 1 608 19,6900 31 662
2026-02-03 Smith Jason Drew 3 217 19,6900 3 217 19,6900 63 343
2026-02-03 Schoenberg Mark 1 843 19,6900 1 843 19,6900 36 289
2026-02-03 Schoenberg Mark 3 686 19,6900 3 686 19,6900 72 577
2026-02-03 Schoenberg Mark 1 844 19,6900 1 844 19,6900 36 308
2025-10-08 Degnan Chris 2 203 16,8500 2 203 16,8500 37 121
2025-09-08 Schoenberg Mark 871 19,1100 871 19,1100 16 645
2025-09-08 Smith Jason Drew 1 520 19,1100 1 520 19,1100 29 047

Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.

URGN / UroGen Pharma Ltd. Insider Trades
Transaktionshistorik

Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.

Fil
datum
Handel
datum
Schema Insider Ticker Värdepappertitel Kod 10b5-1 Direkta Utövningspris Enhet
pris
Enheter
ändrad
Värde
ändrad (1K)
Kvarvarande
Optioner
Kvarvarande
Aktier
2026-05-27 2026-05-26 4 Robinson James A. Jr. URGN ordinary shares M - Exercise D 2 000 6 000
2026-05-11 2026-05-08 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 30,0000 −10 000 −300 134 985
2026-02-27 2025-02-26 4 Robinson James A. Jr. URGN ordinary shares M - Exercise D 2 000 4 000
2026-02-11 2026-02-03 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 19,6900 −3 217 −63 55 588
2026-02-11 2026-02-03 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 19,6900 −1 608 −32 51 326
2026-02-11 2026-02-03 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 19,6900 −2 654 −52 52 934
2026-02-11 2026-01-31 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 6 667 49 972
2026-02-11 2026-01-31 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 3 333 58 805
2026-02-11 2026-01-31 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 5 500 55 472
2026-02-04 2026-02-03 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 19,6900 −3 686 −73 144 985
2026-02-04 2026-02-03 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 19,6900 −1 843 −36 148 671
2026-02-04 2026-02-03 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 19,6900 −1 844 −36 150 514
2026-02-03 2026-01-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 3 334 142 359
2026-02-03 2026-01-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 6 666 152 358
2026-02-03 2026-01-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 3 333 145 692
2025-12-01 2025-11-26 4 Holden Stuart URGN ordinary shares M - Exercise D 2 000 2 000
2025-12-01 2025-11-26 4 BUTITTA CYNTHIA M URGN ordinary shares M - Exercise D 2 000 2 000
2025-12-01 2025-11-26 4 Robinson James A. Jr. URGN ordinary shares M - Exercise D 2 000 2 000
2025-12-01 2025-11-26 4 WEN LEANA URGN ordinary shares M - Exercise D 2 000 2 000
2025-12-01 2025-11-26 4 Wildman Daniel George URGN ordinary shares M - Exercise D 2 000 2 000
2025-11-20 2025-11-19 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 25,0000 −10 000 −250 139 025
2025-10-09 2025-10-08 4 Degnan Chris URGN Ordinary Shares S - Sale D 16,8500 −2 203 −37 2 280
2025-10-09 2025-10-08 4 Degnan Chris URGN Ordinary Shares M - Exercise D 4 483 4 483
2025-09-09 2025-09-08 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 19,1100 −871 −17 149 025
2025-09-09 2025-09-07 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 1 667 149 896
2025-09-09 2025-09-08 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 19,1100 −1 520 −29 43 305
2025-09-09 2025-09-07 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 3 333 44 825
2025-08-13 2025-08-11 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 17,6900 −10 000 −177 148 229
2025-07-30 2025-07-28 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 19,1400 −7 522 −144 41 492
2025-07-30 2025-07-28 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 16 500 49 014
2025-07-30 2025-07-28 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 19,1400 −5 149 −99 158 229
2025-07-30 2025-07-28 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 10 000 163 378
2025-06-11 2025-06-09 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 7,3700 −5 162 −38 153 378
2025-06-11 2025-06-08 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 10 000 158 540
2025-02-04 2025-01-31 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 11,1400 −1 896 −21 148 540
2025-02-04 2025-01-31 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 11,1400 −1 896 −21 148 540
2025-02-04 2025-01-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 3 333 150 436
2025-02-04 2025-01-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 3 333 150 436
2025-02-04 2025-01-31 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 11,1400 −759 −8 145 666
2025-02-04 2025-01-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 1 334 146 425
2025-02-04 2025-01-31 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 11,1400 −2 767 −31 32 514
2025-02-04 2025-01-31 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 5 500 35 281
2025-02-04 2025-01-31 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 11,1400 −3 354 −37 29 781
2025-02-04 2025-01-31 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 6 667 33 135
2025-02-04 2025-01-31 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 11,1400 −1 258 −14 26 468
2025-02-04 2025-01-31 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 2 500 27 726
2024-09-12 2024-09-09 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 13,0800 −859 −11 145 091
2024-09-12 2024-09-09 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 1 666 145 950
2024-09-12 2024-09-09 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 13,0800 −1 521 −20 25 226
2024-09-12 2024-09-09 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 3 333 26 747
2024-09-12 2024-09-09 4 Kim Dong URGN Ordinary Shares M - Exercise D 2 500 37 753
2024-06-11 2024-06-10 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 13,0800 −5 153 −67 144 284
2024-06-11 2024-06-10 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 10 000 149 437
2024-03-20 2024-03-18 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 14,0500 −12 000 −169 139 437
2024-02-12 2024-01-31 4/A Kim Dong URGN Ordinary Shares M - Exercise D 3 333 35 253
2024-02-05 2024-02-01 4/A Smith Jason Drew URGN Ordinary Shares S - Sale D 15,7800 −3 328 −53 23 414
2024-02-05 2024-02-01 4/A Smith Jason Drew URGN Ordinary Shares S - Sale D 15,7800 −1 248 −20 20 076
2024-02-05 2024-02-01 4/A Smith Jason Drew URGN Ordinary Shares S - Sale D 15,7800 −417 −7 18 824
2024-02-05 2024-02-01 4/A Schoenberg Mark URGN Ordinary Shares S - Sale D 15,7800 −1 894 −30 151 437
2024-02-05 2024-02-01 4/A Schoenberg Mark URGN Ordinary Shares S - Sale D 15,7800 −758 −12 149 998
2024-02-05 2024-02-01 4/A Schoenberg Mark URGN Ordinary Shares S - Sale D 15,7800 −1 137 −18 149 423
2024-02-02 2024-01-31 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 15,7400 −3 328 −52 23 414
2024-02-02 2024-01-31 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 6 666 26 742
2024-02-02 2024-01-31 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 15,7400 −1 248 −20 20 076
2024-02-02 2024-01-31 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 2 500 21 324
2024-02-02 2024-01-31 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 15,7400 −417 −7 18 824
2024-02-02 2024-01-31 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 834 19 241
2024-02-02 2024-01-31 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 15,7400 −1 894 −30 151 437
2024-02-02 2024-01-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 3 333 153 331
2024-02-02 2024-01-31 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 15,7400 −758 −12 149 998
2024-02-02 2024-01-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 1 333 150 756
2024-02-02 2024-01-31 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 15,7400 −1 137 −18 149 423
2024-02-02 2024-01-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 2 000 150 560
2024-02-02 2024-01-31 4 Kim Dong URGN Ordinary Shares M - Exercise D 3 333 26 585
2023-09-05 2023-08-31 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 18,0100 −3 800 −68 18 407
2023-09-05 2023-08-31 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 8 334 22 207
2023-07-28 2023-07-26 4 Cohen Fred E by Monograph Capital Partners, for which the reporting person is Chair and Chief Investment Officer URGN Ordinary Shares A - Award I 9,5400 69 339 661 69 339
2023-02-28 2022-06-06 4/A Nussbaum Ran Managing member of entities affiliated with Pontifax Management III G.P. (2011) Ltd. URGN Ordinary Shares M - Exercise I 5,0000 1 030 5 1 434 958
2023-02-28 2022-10-21 4/A Nussbaum Ran Managing member of entities affiliated with Pontifax Management III G.P. (2011) Ltd URGN Ordinary Shares M - Exercise I 5,9400 47 999 285 1 485 168
2023-02-28 2022-06-16 4 Nussbaum Ran Managing member of entities affiliated with Pontifax Management III G.P. (2011) Ltd. URGN Ordinary Shares M - Exercise I 5,0000 2 211 11 1 437 169
2023-02-02 2023-01-31 4 Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 13 333 326 691
2023-02-02 2023-01-31 4 Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 5 000 313 358
2023-02-02 2023-01-31 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 10,1200 −1 227 −12 13 873
2023-02-02 2023-01-31 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 2 500 15 100
2023-02-02 2023-01-31 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 10,1200 −409 −4 12 600
2023-02-02 2023-01-31 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 833 13 009
2023-02-02 2023-01-31 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 10,1200 −661 −7 148 560
2023-02-02 2023-01-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 1 333 149 221
2023-02-02 2023-01-31 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 10,1200 −991 −10 147 888
2023-02-02 2023-01-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 2 000 148 879
2023-02-02 2023-01-31 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 10,1200 −248 −3 146 879
2023-02-02 2023-01-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 500 147 127
2023-01-23 2023-01-20 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 5,0000 122 677 613 146 627
2022-11-02 2022-10-31 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 11,8500 −258 −3 23 950
2022-11-02 2022-10-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 500 24 208
2022-10-25 2022-10-21 4 Nussbaum Ran Managing member of entities affiliated with Pontifax Management III G.P. (2011) Ltd URGN Ordinary Shares M - Exercise I 5,9400 47 999 285 1 481 927
2022-09-16 2022-09-14 4 Belldegrun Arie URGN Ordinary Shares M - Exercise D 5,0000 160 000 800 408 693
2022-09-02 2022-08-31 4 Belldegrun Arie URGN Ordinary Shares M - Exercise D 5,0000 3 241 16 248 693
2022-09-02 2022-08-31 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 7,2100 −3 606 −26 12 176
2022-09-02 2022-08-31 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 8 333 15 782
2022-08-25 2022-06-06 4 Nussbaum Ran Managing member of entities affiliated with Pontifax Management III G.P. (2011) Ltd. URGN Ordinary Shares M - Exercise I 5,0000 1 030 5 1 433 928
2022-08-25 2022-08-01 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 7,8100 −259 −2 23 708
2022-08-25 2022-07-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 500 23 967
2022-05-03 2022-04-30 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D −500 1 500
2022-05-03 2022-04-30 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 6,6200 −254 −2 23 467
2022-05-03 2022-04-30 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 500 23 721
2022-03-29 2022-03-25 4 Kim Dong URGN Employee Stock Option (right to buy) A - Award D 8,61 30 000 30 000
2022-03-29 3 Kim Dong URGN Ordinary Shares D 31 920
2022-02-02 2022-01-31 4 Smith Jason Drew URGN Stock Option (right to buy) A - Award D 7,72 30 000 30 000
2022-02-02 2022-01-31 4 Smith Jason Drew URGN Restricted Stock Units A - Award D 7 500 7 500
2022-02-02 2022-01-31 4 Smith Jason Drew URGN Restricted Stock Units M - Exercise D −833 1 667
2022-02-02 2022-01-31 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 7,5800 −414 −3 7 449
2022-02-02 2022-01-31 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 833 7 863
2022-02-02 2022-01-31 4 Henderson Molly URGN Stock Option (right to buy) A - Award D 7,72 30 000 30 000
2022-02-02 2022-01-31 4 Henderson Molly URGN Restricted Stock Units A - Award D 7 500 7 500
2022-02-02 2022-01-31 4 Henderson Molly URGN Restricted Stock Units M - Exercise D −666 1 334
2022-02-02 2022-01-31 4 Henderson Molly URGN Ordinary Shares S - Sale D 7,5800 −331 −3 5 248
2022-02-02 2022-01-31 4 Henderson Molly URGN Ordinary Shares M - Exercise D 666 5 579
2022-02-02 2022-01-31 4 Barrett Elizabeth A. URGN Stock Option (right to buy) A - Award D 7,72 150 000 150 000
2022-02-02 2022-01-31 4 Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D −13 333 26 667
2022-02-02 2022-01-31 4 Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D −5 000 5 000
2022-02-02 2022-01-31 4 Barrett Elizabeth A. URGN Ordinary Shares S - Sale D 7,5800 −5 960 −45 308 358
2022-02-02 2022-01-31 4 Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 13 333 314 318
2022-02-02 2022-01-31 4 Barrett Elizabeth A. URGN Ordinary Shares S - Sale D 7,5800 −2 235 −17 300 985
2022-02-02 2022-01-31 4 Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 5 000 303 220
2022-02-02 2022-01-31 4 Schoenberg Mark URGN Restricted Stock M - Exercise D −2 000 4 000
2022-02-02 2022-01-31 4 Schoenberg Mark URGN Restricted Stock Units A - Award D 4 000 4 000
2022-02-02 2022-01-31 4 Schoenberg Mark URGN Stock Option (right to buy) A - Award D 7,72 12 064 12 064
2022-02-02 2022-01-31 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D −500 2 000
2022-02-02 2022-01-31 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 7,5800 −1 099 −8 23 221
2022-02-02 2022-01-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 2 000 24 320
2022-02-02 2022-01-31 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 7,5800 −275 −2 22 320
2022-02-02 2022-01-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 500 22 595
2022-01-28 2022-01-26 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D −209 0
2022-01-28 2022-01-26 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 8,0900 −111 −1 22 095
2022-01-28 2022-01-26 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 209 22 206
2022-01-07 2022-01-04 4 Barrett Elizabeth A. URGN Ordinary Shares S - Sale D 9,1500 −46 968 −430 298 220
2022-01-07 2022-01-03 4 Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D −105 689 0
2022-01-07 2022-01-03 4 Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 105 689 345 188
2021-12-02 2021-11-30 4 Smith Jason Drew URGN Restricted Stock Units M - Exercise D −8 333 16 667
2021-12-02 2021-11-30 4 Smith Jason Drew URGN Ordinary Shares S - Sale D 12,0300 −3 803 −46 7 030
2021-12-02 2021-11-30 4 Smith Jason Drew URGN Ordinary Shares M - Exercise D 8 333 10 833
2021-12-02 2021-11-30 4 Henderson Molly URGN Restricted Stock Units M - Exercise D −5 000 10 000
2021-12-02 2021-11-30 4 Henderson Molly URGN Ordinary Shares S - Sale D 12,0300 −2 587 −31 4 913
2021-12-02 2021-11-30 4 Henderson Molly URGN Ordinary Shares M - Exercise D 5 000 7 500
2021-11-19 2021-11-18 4 Schoenberg Mark URGN Ordinary Shares P - Purchase D 13,1000 160 2 21 997
2021-11-02 2021-11-01 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 17,1600 −258 −4 21 837
2021-11-02 2021-10-31 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D −500 2 500
2021-11-02 2021-10-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 500 22 095
2021-10-28 2021-10-27 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 16,3200 −107 −2 21 595
2021-10-28 2021-10-26 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D −208 209
2021-10-28 2021-10-26 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 208 21 702
2021-08-03 2021-08-02 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 15,6400 −243 −4 21 494
2021-08-03 2021-07-31 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D −500 3 000
2021-08-03 2021-07-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 500 21 737
2021-07-28 2021-07-26 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D −208 417
2021-07-28 2021-07-26 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 15,3000 −103 −2 20 821
2021-07-28 2021-07-26 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D −208 20 924
2021-07-12 2020-12-03 4/A Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D −8 808 114 496
2021-07-12 2020-12-03 4/A Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 8 808 219 117
2021-07-12 2020-11-03 4/A Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D −8 808 123 304
2021-07-12 2020-11-03 4/A Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 8 808 210 309
2021-07-12 2020-10-03 4/A Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D −8 808 132 112
2021-07-12 2020-10-03 4/A Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 8 808 201 501
2021-07-12 2020-09-03 4/A Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D −8 807 140 920
2021-07-12 2020-09-03 4/A Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 8 807 192 693
2021-07-12 2020-08-03 4/A Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D −8 807 149 727
2021-07-12 2020-08-03 4/A Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 8 807 183 886
2021-07-12 2020-07-03 4/A Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D −8 807 158 534
2021-07-12 2020-07-03 4/A Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 8 807 175 079
2021-07-12 2020-06-03 4/A Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D −8 807 167 341
2021-07-12 2020-06-03 4/A Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 8 807 166 272
2021-07-12 2020-05-03 4/A Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D −8 808 176 148
2021-07-12 2020-05-03 4/A Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 8 808 157 465
2021-07-12 2020-04-03 4/A Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D −8 807 198 956
2021-07-12 2020-04-03 4/A Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 8 807 148 657
2021-07-12 2020-03-03 4/A Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D −8 807 193 763
2021-07-12 2020-03-03 4/A Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 8 807 139 850
2021-07-12 2020-02-03 4/A Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D −8 807 202 570
2021-07-12 2020-02-03 4/A Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 8 807 131 043
2021-06-09 2021-03-26 4/A Belldegrun Arie URGN Stock Option (right to buy) M - Exercise D 5,00 −3 241 0
2021-06-09 2021-03-26 4/A Belldegrun Arie URGN Ordinary Shares M - Exercise D 5,0000 3 241 16 245 452
2021-06-09 2021-03-25 4/A Nussbaum Ran By Pontifax Cayman III Limited Partnership URGN Stock Option (right to buy) M - Exercise I 5,00 −1 030 0
2021-06-09 2021-03-25 4/A Nussbaum Ran Managing Partner of entities affiliated with Pontifax Management III G.P. ( URGN Ordinary Shares M - Exercise I 5,0000 1 030 5 1 431 717
2021-06-09 2021-06-07 4 Cohen Fred E URGN Stock Option (right to buy) A - Award D 17,98 10 000 10 000
2021-06-09 2021-06-07 4 FALBERG KATHRYN E URGN Stock Option (right to buy) A - Award D 17,98 10 000 10 000
2021-06-09 2021-06-07 4 BUTITTA CYNTHIA M URGN Stock Option (right to buy) A - Award D 17,98 10 000 10 000
2021-06-09 2021-06-07 4 Nussbaum Ran By Pontifax Cayman III Limited Partnership URGN Stock Option (right to buy) A - Award I 17,89 3 183 3 183
2021-06-09 2021-06-07 4 Nussbaum Ran by Pontifax (Israel) III Limited Partnership URGN Stock Option (right to buy) A - Award I 17,89 6 817 6 817
2021-06-09 2021-03-25 4 Nussbaum Ran by Pontifax (Israel) III Limited Partnership URGN Stock Option (right to buy) M - Exercise I 5,00 −2 211 0
2021-06-09 2021-03-25 4 Nussbaum Ran Managing Partner of entities affiliated with Pontifax Management III G.P. URGN Ordinary Shares M - Exercise I 5,0000 2 211 11 1 433 928
2021-06-09 2021-06-07 4 Belldegrun Arie URGN Stock Option (right to buy) A - Award D 17,98 10 000 10 000
2021-06-09 2021-06-07 4 Tomasello Shawn URGN Stock Option (right to buy) A - Award D 17,98 10 000 10 000
2021-06-09 2021-06-07 4 Holden Stuart URGN Stock Option (right to buy) A - Award D 17,98 10 000 10 000
2021-06-08 2021-06-05 4 Smith Jason Drew URGN Stock Option (right to buy) A - Award D 17,98 15 000 15 000
2021-06-08 2021-06-05 4 Henderson Molly URGN Stock Option (right to buy) A - Award D 17,98 15 000 15 000
2021-05-21 2021-05-19 4 Barrett Elizabeth A. URGN Ordinary Shares F - Taxes D 17,5089 −1 240 −22 239 499
2021-05-21 2021-05-19 4 Barrett Elizabeth A. URGN Ordinary Shares F - Taxes D 17,5089 −2 185 −38 240 739
2021-05-21 2021-01-31 4 Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D −5 000 10 000
2021-05-21 2021-01-31 4 Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 5 000 242 924
2021-05-21 2021-01-03 4 Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D −8 807 105 689
2021-05-21 2021-01-03 4 Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 8 807 237 924
2021-05-18 2021-05-17 4 Henderson Molly URGN Common Stock P - Purchase D 15,8500 2 500 40 2 500
2021-05-18 2021-05-17 4 Smith Jason Drew URGN Common Stock P - Purchase D 15,7100 2 500 39 2 500
2021-05-04 2021-04-30 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D −500 3 500
2021-05-04 2021-04-30 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 20,0000 −243 −5 21 132
2021-05-04 2021-04-30 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 500 21 375
2021-04-27 2021-04-26 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D −209 625
2021-04-27 2021-04-26 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 19,6300 −89 −2 20 875
2021-04-27 2021-04-26 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 209 20 964
2021-04-22 2021-03-24 4 Belldegrun Arie URGN Stock Option (right to buy) M - Exercise D 5,00 −3 241 0
2021-04-22 2021-03-24 4 Belldegrun Arie URGN Ordinary Shares M - Exercise D 5,0000 3 241 16 245 452
2021-04-22 2021-03-24 4 Nussbaum Ran By Pontifax Cayman III Limited Partnership URGN Stock Option (right to buy) M - Exercise I 5,00 −1 030 0
2021-04-22 2021-03-24 4 Nussbaum Ran Managing Partner of entities affiliated with Pontifax Management III G.P. ( URGN Ordinary Shares M - Exercise I 5,0000 1 030 5 1 465 199
2021-02-02 2021-01-31 4 Henderson Molly URGN Restricted Stock Units A - Award D 2 000 2 000
2021-02-02 2021-01-31 4 Henderson Molly URGN Stock Option (right to buy) A - Award D 22,07 6 000 6 000
2021-02-02 2021-01-31 4 Smith Jason Drew URGN Restricted Stock Units A - Award D 2 500 2 500
2021-02-02 2021-01-31 4 Smith Jason Drew URGN Stock Option (right to buy) A - Award D 22,07 8 000 8 000
2021-02-02 2021-01-31 4 Barrett Elizabeth A. URGN Restricted Stock Units A - Award D 40 000 40 000
2021-02-02 2021-01-31 4 Barrett Elizabeth A. URGN Stock Option (right to buy) A - Award D 22,07 150 000 150 000
2021-02-02 2021-01-31 4 Schoenberg Mark URGN Restricted Stock Units A - Award D 6 000 6 000
2021-02-02 2021-01-31 4 Schoenberg Mark URGN Stock Option (right to buy) A - Award D 22,07 21 000 21 000
2021-02-02 2021-01-31 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D −2 000 4 000
2021-02-02 2021-01-31 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 22,0700 −1 076 −24 20 755
2021-02-02 2021-01-31 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 2 000 21 831
2021-01-26 2021-01-26 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D −208 834
2021-01-26 2021-01-26 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 22,1200 −100 −2 19 831
2021-01-26 2021-01-26 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 208 19 931
2020-12-15 2020-12-14 4 Barrett Elizabeth A. URGN Ordinary Shares P - Purchase D 18,5000 10 000 185 229 117
2020-12-07 2020-12-04 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D −1 042 0
2020-12-07 2020-12-04 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 19,8500 −662 −13 19 723
2020-12-07 2020-12-04 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 1 042 20 385
2020-12-04 2020-12-04 4 Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D −61 652 114 496
2020-12-04 2020-12-04 4 Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 61 652 219 117
2020-10-28 2020-10-26 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D −208 1 042
2020-10-28 2020-10-26 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 20,9461 −101 −2 19 343
2020-10-28 2020-10-26 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 208 19 444
2020-10-16 2020-10-15 4 PFREUNDSCHUH PETER P. URGN Restricted Stock Units M - Exercise D −2 000 4 000
2020-10-16 2020-10-15 4 PFREUNDSCHUH PETER P. URGN Restricted Stock Units M - Exercise D −2 084 2 082
2020-10-16 2020-10-15 4 PFREUNDSCHUH PETER P. URGN Restricted Stock Units M - Exercise D −833 1 667
2020-10-16 2020-10-15 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares S - Sale D 21,7200 −1 017 −22 10 405
2020-10-16 2020-10-15 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares S - Sale D 21,8243 −407 −9 11 422
2020-10-16 2020-10-15 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares S - Sale D 21,7992 −976 −21 11 829
2020-10-16 2020-10-15 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares M - Exercise D 4 917 12 805
2020-10-05 2020-10-01 4/A Smith Jason Drew URGN Restricted Stock Unit A - Award D 25 000 25 000
2020-10-05 2020-10-01 4/A Smith Jason Drew URGN Employee Stock Option (right to buy) A - Award D 19,66 60 000 60 000
2020-10-05 2020-10-01 4 Henderson Molly URGN Restricted Stock Units A - Award D 15 000 15 000
2020-10-05 2020-10-01 4 Henderson Molly URGN Stock Option (Right to Buy) A - Award D 19,66 60 000 60 000
2020-09-10 2020-09-09 4 Smith Jason Drew URGN Restricted Stock Unit A - Award D 25 000 25 000
2020-09-10 2020-09-09 4 Smith Jason Drew URGN Employee Stock Option (right to buy) A - Award D 21,38 60 000 60 000
2020-09-08 2020-09-04 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D −1 041 1 042
2020-09-08 2020-09-04 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 20,2000 −348 −7 19 236
2020-09-08 2020-09-04 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 1 041 19 584
2020-09-01 2020-09-01 4 PFREUNDSCHUH PETER P. URGN Restricted Stock Units M - Exercise D −1 042 4 166
2020-09-01 2020-09-01 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares S - Sale D 22,8200 −509 −12 7 888
2020-09-01 2020-09-01 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares M - Exercise D 1 042 8 397
2020-07-28 2020-07-27 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 23,5100 −70 −2 18 543
2020-07-28 2020-07-26 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D −209 1 250
2020-07-28 2020-07-26 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 209 18 613
2020-07-28 2020-07-27 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares S - Sale D 23,5100 −141 −3 7 355
2020-07-28 2020-07-26 4 PFREUNDSCHUH PETER P. URGN Restricted Stock Units M - Exercise D −417 2 500
2020-07-28 2020-07-26 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares M - Exercise D 417 7 496
2020-06-10 2020-06-08 4 Belldegrun Arie URGN Stock Option (right to buy) A - Award D 28,24 10 000 10 000
2020-06-10 2020-06-08 4 BUTITTA CYNTHIA M URGN Stock Option (right to buy) A - Award D 28,24 10 000 10 000
2020-06-10 2020-06-08 4 Cohen Fred E URGN Stock Option (right to buy) A - Award D 28,24 10 000 10 000
2020-06-10 2020-06-08 4 FALBERG KATHRYN E URGN Stock Option (right to buy) A - Award D 28,24 10 000 10 000
2020-06-10 2020-06-08 4 Holden Stuart URGN Stock Option (right to buy) A - Award D 28,24 10 000 10 000
2020-06-10 2020-06-08 4 Nussbaum Ran URGN Stock Option (right to buy) A - Award D 28,24 10 000 10 000
2020-06-10 2020-06-08 4 Tomasello Shawn URGN Stock Option (right to buy) A - Award D 28,24 10 000 10 000
2020-06-05 2020-06-04 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D −1 042 2 083
2020-06-05 2020-06-04 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 27,5128 −349 −10 18 404
2020-06-05 2020-06-04 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 1 042 18 753
2020-05-20 2020-05-20 4 PFREUNDSCHUH PETER P. URGN Restricted Stock Units M - Exercise D −1 041 5 208
2020-05-20 2020-05-20 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares S - Sale D 25,0700 −358 −9 7 079
2020-05-20 2020-05-20 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares M - Exercise D 1 041 7 437
2020-05-14 2020-05-12 4 Barrett Elizabeth A. URGN Restricted Stock Units M - Exercise D −35 229 176 148
2020-05-14 2020-05-12 4 Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 35 229 157 465
2020-04-28 2020-04-27 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 24,3500 −70 −2 17 711
2020-04-28 2020-04-26 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D −208 1 459
2020-04-28 2020-04-26 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 208 17 781
2020-04-28 2020-04-27 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares S - Sale D 24,3500 −141 −3 6 396
2020-04-28 2020-04-26 4 PFREUNDSCHUH PETER P. URGN Restricted Stock Units M - Exercise D −417 2 917
2020-04-28 2020-04-26 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares M - Exercise D 417 6 537
2020-04-28 2020-04-27 4 Mullennix Stephen URGN Ordinary Shares S - Sale D 24,3500 −145 −4 10 084
2020-04-28 2020-04-26 4 Mullennix Stephen URGN Restricted Stock Units (RSUs) M - Exercise D −417 2 917
2020-04-28 2020-04-26 4 Mullennix Stephen URGN Ordinary Shares M - Exercise D 417 10 229
2020-03-04 2020-03-04 4 Schoenberg Mark URGN Restricted Stock Units M - Exercise D −1 042 3 125
2020-03-04 2020-03-04 4 Schoenberg Mark URGN Ordinary Shares F - Taxes D 29,5000 −345 −10 17 573
2020-03-04 2020-03-04 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 1 042 17 918
2020-02-24 2020-02-20 4 PFREUNDSCHUH PETER P. URGN Restricted Stock Units M - Exercise D −1 042 6 249
2020-02-24 2020-02-20 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares S - Sale D 29,6800 −360 −11 6 120
2020-02-24 2020-02-20 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares M - Exercise D 1 042 6 480
2020-02-18 2020-02-14 4 Mullennix Stephen URGN Restricted Stock Units M - Exercise D −1 759 7 037
2020-02-18 2020-02-14 4 Mullennix Stephen URGN Ordinary Shares S - Sale D 28,0400 −612 −17 9 812
2020-02-18 2020-02-14 4 Mullennix Stephen URGN Ordinary Shares M - Exercise D 1 759 10 424
2020-02-13 3/A Belldegrun Arie URGN Ordinary Shares D 114 211
2020-02-13 3/A Schoenberg Mark URGN Ordinary Shares D 12 986
2020-02-04 2020-01-31 4 Barrett Elizabeth A. URGN Restricted Stock Unit A - Award D 15 000 15 000
2020-02-04 2020-01-31 4 Barrett Elizabeth A. URGN Stock options (right to buy) A - Award D 29,41 45 000 45 000
2020-02-04 2020-01-31 4 Schoenberg Mark URGN Restricted stock unit A - Award D 6 000 6 000
2020-02-04 2020-01-31 4 Schoenberg Mark URGN Stock options (right to buy) A - Award D 29,41 15 000 15 000
2020-02-04 2020-01-31 4 Mullennix Stephen URGN Restricted stock unit A - Award D 3 000 3 000
2020-02-04 2020-01-31 4 Mullennix Stephen URGN Stock options (right to buy) A - Award D 29,41 15 000 15 000
2020-02-04 2020-01-31 4 PFREUNDSCHUH PETER P. URGN Restricted Stock Unit A - Award D 6 000 6 000
2020-02-04 2020-01-31 4 PFREUNDSCHUH PETER P. URGN Stock options (right to buy) A - Award D 29,41 15 000 15 000
2020-01-28 2020-01-27 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 29,1500 −322 −9 9 177
2020-01-28 2020-01-26 4 Schoenberg Mark URGN Restricted Stock Units (RSUs) M - Exercise D −833 1 667
2020-01-28 2020-01-26 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 833 9 499
2020-01-28 2020-01-27 4 Mullennix Stephen URGN Ordinary Shares S - Sale D 29,2600 −684 −20 8 665
2020-01-28 2020-01-26 4 Mullennix Stephen URGN Restricted Stock Units (RSUs) M - Exercise D −1 666 3 334
2020-01-28 2020-01-26 4 Mullennix Stephen URGN Ordinary Shares M - Exercise D 1 666 9 349
2020-01-28 2020-01-27 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares S - Sale D 29,2800 −667 −20 4 438
2020-01-28 2020-01-26 4 PFREUNDSCHUH PETER P. URGN Restricted Stock Units (RSUs) M - Exercise D −1 666 3 334
2020-01-28 2020-01-26 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares M - Exercise D 1 666 5 105
2020-01-07 2020-01-03 4 Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D −105 688 211 377
2020-01-07 2020-01-03 4 Barrett Elizabeth A. URGN Ordinary Shares M - Exercise D 105 688 122 236
2019-12-05 2019-12-04 4 Schoenberg Mark URGN Restricted Stock Units (RSUs) M - Exercise D −1 042 4 167
2019-12-05 2019-12-04 4 Schoenberg Mark URGN Ordinary Shares F - Taxes D 31,6900 −343 −11 8 666
2019-12-05 2019-12-04 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 1 042 9 009
2019-11-22 2019-11-21 4 Barrett Elizabeth A. URGN Ordinary Shares P - Purchase D 28,0000 7 530 211 16 548
2019-11-22 2019-11-20 4 PFREUNDSCHUH PETER P. URGN Restricted Stock Units M - Exercise D −1 042 7 291
2019-11-22 2019-11-20 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares S - Sale D 28,4100 −354 −10 3 439
2019-11-22 2019-11-20 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares M - Exercise D 1 042 3 793
2019-11-22 2019-11-20 4 Barrett Elizabeth A. URGN Ordinary Shares P - Purchase D 28,0000 7 470 209 9 018
2019-11-21 2019-11-19 4 Schoenberg Mark By Mark Schoenberg Pension Plan FBO Mark Schoenberg URGN Ordinary Shares P - Purchase I 28,1700 1 960 55 7 967
2019-11-18 2019-11-15 4 Barrett Elizabeth A. URGN Ordinary Shares P - Purchase D 26,0000 1 548 40 1 548
2019-11-18 2019-11-14 4 Mullennix Stephen URGN Restricted Stock Units M - Exercise D −1 759 8 796
2019-11-18 2019-11-14 4 Mullennix Stephen URGN Ordinary Shares S - Sale D 25,9973 −608 −16 7 683
2019-11-18 2019-11-14 4 Mullennix Stephen URGN Ordinary Shares M - Exercise D 1 759 8 291
2019-09-06 2019-09-04 4 Schoenberg Mark URGN Restricted Stock Units (RSUs) M - Exercise D −1 041 5 209
2019-09-06 2019-09-04 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 33,9200 −343 −12 6 007
2019-09-06 2019-09-04 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 1 041 6 350
2019-08-22 2019-08-20 4 PFREUNDSCHUH PETER P. URGN Restricted Stock Units M - Exercise D −4 167 8 333
2019-08-22 2019-08-20 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares S - Sale D 33,0700 −1 416 −47 2 751
2019-08-22 2019-08-20 4 PFREUNDSCHUH PETER P. URGN Ordinary Shares M - Exercise D 4 167 4 167
2019-08-16 2019-08-15 4 Mullennix Stephen URGN Ordinary Shares S - Sale D 31,6500 −608 −19 6 532
2019-08-16 2019-08-14 4 Mullennix Stephen URGN Restricted Stock Units M - Exercise D −1 759 10 555
2019-08-16 2019-08-14 4 Mullennix Stephen URGN Ordinary Shares M - Exercise D 1 759 7 140
2019-06-06 2019-06-04 4 Schoenberg Mark URGN Restricted Stock Units (RSUs) M - Exercise D −1 042 6 250
2019-06-06 2019-06-04 4 Schoenberg Mark URGN Ordinary Shares F - Taxes D 35,0500 −343 −12 5 309
2019-06-06 2019-06-04 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 1 042 5 652
2019-06-05 2019-06-03 4 Belldegrun Arie URGN Stock Option (Right to Buy) A - Award D 34,83 10 000 10 000
2019-06-05 2019-06-03 4 Holden Stuart URGN Stock Option (Right to Buy) A - Award D 34,83 10 000 10 000
2019-06-05 2019-06-03 4 Nussbaum Ran URGN Stock Option (Right to Buy) A - Award D 34,83 10 000 10 000
2019-06-05 2019-06-03 4 Cohen Fred E URGN Stock Option (Right to Buy) A - Award D 34,83 10 000 10 000
2019-06-05 2019-06-03 4 BUTITTA CYNTHIA M URGN Stock Option (Right to Buy) A - Award D 34,83 10 000 10 000
2019-06-05 2019-06-03 4 FALBERG KATHRYN E URGN Stock Option (Right to Buy) A - Award D 34,83 10 000 10 000
2019-06-05 2019-06-03 4 Tomasello Shawn URGN Stock Option (Right to Buy) A - Award D 34,83 10 000 10 000
2019-05-16 2019-05-14 4 Mullennix Stephen URGN Restricted Stock Units M - Exercise D −1 759 12 314
2019-05-16 2019-05-14 4 Mullennix Stephen URGN Ordinary Shares S - Sale D 37,9800 −608 −23 5 381
2019-05-16 2019-05-14 4 Mullennix Stephen URGN Ordinary Shares M - Exercise D 1 759 5 989
2019-03-28 2019-03-27 4 Belldegrun Arie URGN Stock Option (right to buy M - Exercise D 4,02 4,0200 −128 000 −515 0
2019-03-28 2019-03-27 4 Belldegrun Arie URGN Ordinary Shares M - Exercise D 4,0200 128 000 515 212 211
2019-03-22 2019-02-06 4 Cohen Fred E URGN Stock Option (Right to Buy) M - Exercise D 16,99 −15 000 25 000
2019-03-22 2019-02-06 4 Cohen Fred E URGN Ordinary Shares M - Exercise D 16,9900 15 000 255 15 000
2019-03-22 2019-03-21 4 Schoenberg Mark URGN Ordinary Shares P - Purchase D 37,0090 272 10 4 610
2019-03-07 3/A Schoenberg Mark URGN Ordinary Shares D 5 287
2019-03-07 2019-02-14 4 Mullennix Stephen URGN Restricted Stock Units M - Exercise D −7 034 14 073
2019-03-07 2019-02-14 4 Mullennix Stephen URGN Ordinary Shares S - Sale D 37,3000 −2 804 −105 4 230
2019-03-07 2019-02-14 4 Mullennix Stephen URGN Ordinary Shares M - Exercise D 7 034 7 034
2019-03-07 2019-03-06 4 Schoenberg Mark URGN Ordinary Shares S - Sale D 37,3000 −1 991 −74 4 338
2019-03-07 2019-03-04 4 Schoenberg Mark URGN Restricted Stock Units (RSUs) M - Exercise D −1 042 7 292
2019-03-07 2019-03-04 4 Schoenberg Mark URGN Ordinary Shares M - Exercise D 1 042 6 329
2019-01-29 2019-01-26 4 Schoenberg Mark URGN Restricted Stock Unit A - Award D 2 500 2 500
2019-01-29 2019-01-26 4 Schoenberg Mark URGN Employee Stock Option (right to buy) A - Award D 42,50 7 500 7 500
2019-01-29 2019-01-26 4 PFREUNDSCHUH PETER P. URGN Restricted Stock Unit A - Award D 5 000 5 000
2019-01-29 2019-01-26 4 PFREUNDSCHUH PETER P. URGN Employee Stock Option (right to buy) A - Award D 42,50 15 000 15 000
2019-01-29 2019-01-26 4 Mullennix Stephen URGN Restricted Stock Unit A - Award D 5 000 5 000
2019-01-29 2019-01-26 4 Mullennix Stephen URGN Employee Stock Option (right to buy) A - Award D 42,50 15 000 15 000
2019-01-10 3 Belldegrun Arie URGN Ordinary Shares D 168 422
2019-01-10 3 Belldegrun Arie URGN Ordinary Shares D 168 422
2019-01-10 3 Belldegrun Arie URGN Ordinary Shares D 168 422
2019-01-10 3 BENTSUR RON URGN Ordinary Shares D 76 226
2019-01-10 3 BENTSUR RON URGN Ordinary Shares D 76 226
2019-01-10 3 BENTSUR RON URGN Ordinary Shares D 76 226
2019-01-10 3 Nussbaum Ran URGN Ordinary Shares I 1 872 849
2019-01-10 3 Nussbaum Ran URGN Ordinary Shares I 2 389 212
2019-01-10 3 Nussbaum Ran URGN Ordinary Shares I 2 389 212
2019-01-10 3 Nussbaum Ran URGN Ordinary Shares I 2 389 212
2019-01-10 3 Nussbaum Ran URGN Ordinary Shares I 1 872 849
2019-01-10 3 Nussbaum Ran URGN Ordinary Shares I 1 872 849
2019-01-10 3 PFREUNDSCHUH PETER P. URGN Ordinary Shares D 2 000
2019-01-10 3 PFREUNDSCHUH PETER P. URGN Ordinary Shares D 2 000
2019-01-10 3 PFREUNDSCHUH PETER P. URGN Ordinary Shares D 2 000
2019-01-10 3 Schoenberg Mark URGN Ordinary Shares D 2 242
2019-01-10 3 Schoenberg Mark URGN Ordinary Shares D 2 242
2019-01-10 3 Schoenberg Mark URGN Ordinary Shares D 2 242
2019-01-09 2018-01-03 4 Barrett Elizabeth A. URGN Restricted Stock Unit A - Award D 317 065 317 065
2019-01-09 2018-01-03 4 Barrett Elizabeth A. URGN Employee Stock Option (right to buy) A - Award D 47,57 277 432 277 432
2017-11-29 2017-11-28 4 ProQuest Investments IV, L.P. URGN Ordinary Shares, par value NIS 0.01 per share S - Sale D 40,5100 −177 807 −7 203 1 242 031
2017-11-29 2017-11-27 4 ProQuest Investments IV, L.P. URGN Ordinary Shares, par value NIS 0.01 per share S - Sale D 41,1200 −31 491 −1 295 1 419 838
2017-07-20 3 ProQuest Investments IV, L.P. URGN Ordinary Shares, par value NIS 0.01 per share D 2 902 658
2017-07-20 3 ProQuest Investments IV, L.P. URGN Ordinary Shares, par value NIS 0.01 per share D 2 902 658
2017-07-20 3 ProQuest Investments IV, L.P. URGN Ordinary Shares, par value NIS 0.01 per share D 2 902 658
2017-07-20 3 ProQuest Investments IV, L.P. URGN Ordinary Shares, par value NIS 0.01 per share D 2 902 658
2017-07-20 3 ProQuest Investments IV, L.P. URGN Ordinary Shares, par value NIS 0.01 per share D 2 902 658
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
DE:UR8 22,57 €
GB:0XOD 28,31 US$
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista